Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease
For the first time, allergic diseases have emerged as major public health concerns. Highly effective therapies for allergic disease now exist, but are plagued by serious side effects and the fact that a significant minority of patients remains unresponsive. Studies from many laboratories have established that T helper type 2 (TH2) cytokines contribute importantly to diseases such as asthma, and therapeutic strategies that target the key TH2 cytokines are of potential benefit in allergic...[Show more]
|Collections||ANU Research Publications|
|Source:||Pharmacology and Therapeutics|
|01_Foster_Interleukins-4,_-5,_and_-13:_2002.pdf||391.69 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.